Seema Dawood: Acquired Platelet Dysfunction with Eosinophilia – Bleeding Despite Normal Platelet Count
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Acquired Platelet Dysfunction with Eosinophilia (APDE)
Condition characterized by bleeding tendency due to abnormal Platelet function, despite having a normal or near-normal platelet count, occurring together with Eosinophilia (increased Eosinophils in the blood).
Key Features
Patients present with abnormal bleeding: purpura, epistaxis, gum bleeding, etc.
Platelet count is usually normal, but platelet function is impaired.
Eosinophilia is present, commonly associated with:
- Parasitic infections
- Allergic diseases
- Certain immune-mediated conditions
Pathophysiology
Eosinophils release toxic granule proteins (e.g., Major Basic Protein, Eosinophil Cationic Protein).
These substances interfere with platelet function (aggregation and adhesion).
Result: ineffective hemostasis despite normal platelet count.
Clinical Importance
- Patients may have bleeding tendency even though platelet count is normal.
- Reported frequently in regions with high prevalence of parasitic infections (e.g., Southeast Asia).
- Treatment focuses on managing the underlying cause of Eosinophilia (e.g., treating parasitic infections).
- Once eosinophil count decreases, platelet function usually improves.
Summary:
APDE is an acquired condition where platelet dysfunction occurs in association with Eosinophilia, leading to bleeding tendency despite normal platelet count.
It is often linked to parasitic infections or allergies and improves when Eosinophilia is treated.
APDE is the only disease in which Pale Platelets are found.
Therefore, before reporting Pale Platelets, it is important to consider other consistent findings such as marked eosinophilia and the presence of purpura in the patient.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers